Related Experiment Video
Updated: Jun 2, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
A study on the oncogenes gli, fos, jun and met in human uterine leiomyomas
Abstract:
122 human uterine leiomyomas, representing the main chromosomal aberrations seen in these tumours, were analyzed by Southern blotting. Probes for the four oncogenes, gli, fos, jun, and met, all localized in or close to the chromosomal breakpoints in leiomyomas, were used. In only one single leiomyoma, with a 7p+q- marker, was there evidence of rearrangement of one of the oncogenes, namely met.
Insights
Researchers analyzed 122 uterine leiomyomas for chromosomal aberrations and oncogene rearrangements. Rearrangement of the met oncogene was found in only one leiomyoma with a specific chromosomal marker.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Uterine leiomyomas are common benign tumors associated with chromosomal abnormalities.
- Specific chromosomal breakpoints in leiomyomas often involve regions with known oncogenes.
Purpose of the Study:
- To investigate the potential involvement of four specific oncogenes (gli, fos, jun, met) in the development of human uterine leiomyomas.
- To correlate chromosomal aberrations with oncogene rearrangements in leiomyoma tissue.
Main Methods:
- Southern blotting technique was employed to analyze DNA from 122 human uterine leiomyomas.
- Probes for the oncogenes gli, fos, jun, and met were used to detect potential gene rearrangements.
Main Results:
- Chromosomal aberrations characteristic of leiomyomas were observed.
- Rearrangement of the met oncogene was detected in only one leiomyoma exhibiting a 7p+q- chromosomal marker.
- No rearrangements were found for the gli, fos, or jun oncogenes in the analyzed samples.
Conclusions:
- The study suggests that chromosomal aberrations in uterine leiomyomas are not frequently associated with rearrangements of the investigated oncogenes (gli, fos, jun, met).
- The met oncogene may play a role in a small subset of leiomyomas with specific chromosomal abnormalities.